[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Point of Care Coagulation Testing Market Size, Trends, Analysis, and Outlook By Technology (Optical Technology, Mechanical Technology, Electrochemical Technology), By Distribution Channel (Direct Tenders, Retail), By End-User (Hospitals, Clinics, Home care), by Region, Country, Segment, and Companies, 2024-2030

March 2024 | 190 pages | ID: PB0ED13F774BEN
VPAResearch

US$ 3,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Point of Care Coagulation Testing market size is poised to register 6.14% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Point of Care Coagulation Testing market By Technology (Optical Technology, Mechanical Technology, Electrochemical Technology), By Distribution Channel (Direct Tenders, Retail), By End-User (Hospitals, Clinics, Home care).

The future of point-of-care (POC) coagulation testing is shaped by advancements in assay technology, cartridge-based systems, and digital connectivity to enable rapid, accurate, and personalized assessment of hemostasis and anticoagulation status in patients requiring thromboembolic risk stratification, perioperative management, or antithrombotic therapy monitoring. Key trends include the development of handheld coagulometers with near-patient testing capabilities, disposable test cartridges, and fingerstick blood sampling for decentralized testing in primary care clinics, anticoagulation clinics, and home healthcare settings, facilitating timely diagnosis, treatment optimization, and patient self-management of bleeding disorders or thrombotic events. Additionally, there is growing integration of POC coagulation analyzers with electronic medical records (EMRs), mobile health apps, and telemedicine platforms for real-time data capture, remote consultation, and collaborative care coordination between patients and healthcare providers, empowering patients to actively participate in their anticoagulant therapy management and adherence to prescribed treatment plans. Moreover, there is increasing demand for point-of-care coagulation tests that offer high sensitivity, specificity, and reproducibility, as well as simplified interpretation algorithms and actionable results, to support clinical decision-making, reduce healthcare resource utilization, and improve patient outcomes, driving innovation and adoption in the field of POC coagulation testing..

Point of Care Coagulation Testing Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Point of Care Coagulation Testing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Point of Care Coagulation Testing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Point of Care Coagulation Testing industry.

Key market trends defining the global Point of Care Coagulation Testing demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Point of Care Coagulation Testing Market Segmentation- Industry Share, Market Size, and Outlook to 2030

The Point of Care Coagulation Testing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Point of Care Coagulation Testing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Point of Care Coagulation Testing industry

Leading Point of Care Coagulation Testing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Point of Care Coagulation Testing companies.

Point of Care Coagulation Testing Market Study- Strategic Analysis Review

The Point of Care Coagulation Testing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
  • Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
  • Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
  • Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
  • Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
Point of Care Coagulation Testing Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Point of Care Coagulation Testing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.

Point of Care Coagulation Testing Country Analysis and Revenue Outlook to 2030

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.

North America Point of Care Coagulation Testing Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Point of Care Coagulation Testing market segments. Similarly, Strong end-user demand is encouraging Canadian Point of Care Coagulation Testing companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Point of Care Coagulation Testing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Point of Care Coagulation Testing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Point of Care Coagulation Testing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Point of Care Coagulation Testing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Point of Care Coagulation Testing Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Point of Care Coagulation Testing in Asia Pacific. In particular, China, India, and South East Asian Point of Care Coagulation Testing markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.

Latin America Point of Care Coagulation Testing Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Point of Care Coagulation Testing Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Point of Care Coagulation Testing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Point of Care Coagulation Testing.

Point of Care Coagulation Testing Market Company Profiles

The global Point of Care Coagulation Testing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are A&T Corp, Abbott Laboratories, Beijing Succeeder Technology Inc, Bio Group Medical System, Danaher Corp, Diagnostica Stago SAS, F. Hoffmann-La Roche Ltd, Genrui Biotech Co. Ltd, Helena Laboratories Corp, Horiba Ltd , Hycel, Maccura Biotechnology Co. Ltd, Nihon Kohden Corp, Siemens, Sysmex Corp, Thermo Fisher Scientific Inc .

Recent Point of Care Coagulation Testing Market Developments

The global Point of Care Coagulation Testing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Point of Care Coagulation Testing Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • SWOT Profile
  • Market Dynamics- Trends, Drivers, Challenges
  • Porter’s Five Forces Analysis
  • Macroeconomic Impact Analysis
  • Case Scenarios- Low, Base, High
Market Segmentation:

By Type

Stationary 3D and 4D Ultrasound Devices

Portable 3D and 4D Ultrasound Devices

By Display

Color Ultrasound

B/W Ultrasound

By Portability

Trolley or Cart-Based Ultrasound Systems

Compact/Handheld Ultrasound Systems

Point-of-Pare (PoC) Ultrasound Systems

By Application

Radiology or General Imaging

Obstetrics or Gynecology

Cardiology

Urology

Vascular

Orthopedic and Musculoskeletal

Pain Management

Others

By End-User

Hospitals

Surgical Centers and Diagnostic Centers

Maternity Centers

Ambulatory Care Centers

Research and Academia

Others

Geographical Segmentation:
  • North America (3 markets)
  • Europe (6 markets)
  • Asia Pacific (6 markets)
  • Latin America (3 markets)
  • Middle East Africa (5 markets)
Companies

A&T Corp

Abbott Laboratories

Beijing Succeeder Technology Inc

Bio Group Medical System

Danaher Corp

Diagnostica Stago SAS

F. Hoffmann-La Roche Ltd

Genrui Biotech Co. Ltd

Helena Laboratories Corp

Horiba Ltd

Hycel

Maccura Biotechnology Co. Ltd

Nihon Kohden Corp

Siemens

Sysmex Corp

Thermo Fisher Scientific Inc

Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY

1.1 Point of Care Coagulation Testing Market Overview and Key Findings, 2024
1.2 Point of Care Coagulation Testing Market Size and Growth Outlook, 2021- 2030
1.3 Point of Care Coagulation Testing Market Growth Opportunities to 2030
1.4 Key Point of Care Coagulation Testing Market Trends and Challenges
  1.4.1 Point of Care Coagulation Testing Market Drivers and Trends
  1.4.2 Point of Care Coagulation Testing Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Point of Care Coagulation Testing Companies

2. POINT OF CARE COAGULATION TESTING MARKET SIZE OUTLOOK TO 2030

2.1 Point of Care Coagulation Testing Market Size Outlook, USD Million, 2021- 2030
2.2 Point of Care Coagulation Testing Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024

3. POINT OF CARE COAGULATION TESTING MARKET- STRATEGIC ANALYSIS REVIEW

3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis

4. POINT OF CARE COAGULATION TESTING MARKET SEGMENTATION ANALYSIS AND OUTLOOK

4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Stationary 3D and 4D Ultrasound Devices
Portable 3D and 4D Ultrasound Devices
By Display
Color Ultrasound
B/W Ultrasound
By Portability
Trolley or Cart-Based Ultrasound Systems
Compact/Handheld Ultrasound Systems
Point-of-Pare (PoC) Ultrasound Systems
By Application
Radiology or General Imaging
Obstetrics or Gynecology
Cardiology
Urology
Vascular
Orthopedic and Musculoskeletal
Pain Management
Others
By End-User
Hospitals
Surgical Centers and Diagnostic Centers
Maternity Centers
Ambulatory Care Centers
Research and Academia
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030

5. REGION-WISE MARKET OUTLOOK TO 2030

5.1 Key Findings for Asia Pacific Point of Care Coagulation Testing Market, 2025
5.2 Asia Pacific Point of Care Coagulation Testing Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Point of Care Coagulation Testing Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Point of Care Coagulation Testing Market, 2025
5.5 Europe Point of Care Coagulation Testing Market Size Outlook by Type, 2021- 2030
5.6 Europe Point of Care Coagulation Testing Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Point of Care Coagulation Testing Market, 2025
5.8 North America Point of Care Coagulation Testing Market Size Outlook by Type, 2021- 2030
5.9 North America Point of Care Coagulation Testing Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Point of Care Coagulation Testing Market, 2025
5.11 South America Pacific Point of Care Coagulation Testing Market Size Outlook by Type, 2021- 2030
5.12 South America Point of Care Coagulation Testing Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Point of Care Coagulation Testing Market, 2025
5.14 Middle East Africa Point of Care Coagulation Testing Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Point of Care Coagulation Testing Market Size Outlook by Application, 2021- 2030

6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030

6.1 US Point of Care Coagulation Testing Market Size Outlook and Revenue Growth Forecasts
6.2 US Point of Care Coagulation Testing Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Point of Care Coagulation Testing Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Point of Care Coagulation Testing Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Point of Care Coagulation Testing Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Point of Care Coagulation Testing Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Point of Care Coagulation Testing Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Point of Care Coagulation Testing Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Point of Care Coagulation Testing Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Point of Care Coagulation Testing Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Point of Care Coagulation Testing Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Point of Care Coagulation Testing Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Point of Care Coagulation Testing Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Point of Care Coagulation Testing Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Point of Care Coagulation Testing Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Point of Care Coagulation Testing Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Point of Care Coagulation Testing Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Point of Care Coagulation Testing Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Point of Care Coagulation Testing Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Point of Care Coagulation Testing Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Point of Care Coagulation Testing Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Point of Care Coagulation Testing Industry Drivers and Opportunities

7. POINT OF CARE COAGULATION TESTING MARKET OUTLOOK ACROSS SCENARIOS

7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case

8. POINT OF CARE COAGULATION TESTING COMPANY PROFILES

8.1 Profiles of Leading Point of Care Coagulation Testing Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
A&T Corp
Abbott Laboratories
Beijing Succeeder Technology Inc
Bio Group Medical System
Danaher Corp
Diagnostica Stago SAS
F. Hoffmann-La Roche Ltd
Genrui Biotech Co. Ltd
Helena Laboratories Corp
Horiba Ltd
Hycel
Maccura Biotechnology Co. Ltd
Nihon Kohden Corp
Siemens
Sysmex Corp
Thermo Fisher Scientific Inc

9. APPENDIX

9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information


More Publications